1. Home
  2. GTE vs VYGR Comparison

GTE vs VYGR Comparison

Compare GTE & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gran Tierra Energy Inc.

GTE

Gran Tierra Energy Inc.

HOLD

Current Price

$8.70

Market Cap

209.3M

Sector

Energy

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.10

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTE
VYGR
Founded
2003
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
209.3M
194.0M
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
GTE
VYGR
Price
$8.70
$4.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$21.00
AVG Volume (30 Days)
919.0K
890.9K
Earning Date
03-03-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$374,460,000.00
$10,135,000.00
Revenue This Year
$3.67
$33.19
Revenue Next Year
$0.41
$14.68
P/E Ratio
N/A
N/A
Revenue Growth
41.99
N/A
52 Week Low
$3.09
$2.65
52 Week High
$8.88
$5.55

Technical Indicators

Market Signals
Indicator
GTE
VYGR
Relative Strength Index (RSI) 65.40 52.14
Support Level $3.75 $3.61
Resistance Level N/A $4.43
Average True Range (ATR) 0.52 0.31
MACD -0.01 -0.04
Stochastic Oscillator 71.97 30.24

Price Performance

Historical Comparison
GTE
VYGR

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: